FDA Authorizes Novavax Vaccine for Ages 12 to 17

August 22, 2022

(Axios) – The Food and Drug Administration has authorized Novavax’s COVID-19 vaccine for emergency use for adolescents between the ages of 12 and 17, the biotech company announced Friday.  Why it matters: The news could be a boon for unvaccinated people who prefer a shot that is not based on the mRNA technology used by Pfizer and Moderna. (Read More)